Amplitude Therapeutics
Building the future of RNA Medicine.
- Business Model
- B2B
- Website
- amplitude-tx.com
- Total Funding
- $1.0M
- Last Round
- $1.0M GrantMar 2024
- Rounds
- 1
About
Amplitude Therapeutics is a biotechnology company focused on developing trans-amplifying mRNA (ta-mRNA) and self-amplifying RNA technologies for next-generation vaccine applications. The company's platform leverages RNA amplification to enable lower-dose, more potent vaccines, with preclinical programs targeting infectious disease indications. Amplitude Therapeutics aims to build the future of RNA medicine by combining innovative RNA delivery and amplification approaches to address unmet medical needs in vaccinology.
Summary
Amplitude Therapeutics is a Biotech company. It has raised $1.0M in total across 1 round, most recently a $1.0M Grant round in Mar 2024. Investors include Coalition for Epidemic Preparedness Innovations (CEPI).
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amplitude-therapeutics"><img src="https://indexed.vc/api/badge/company/amplitude-therapeutics" alt="Amplitude Therapeutics on Indexed.vc" width="260" height="76" /></a>